HOME >> BIOLOGY >> NEWS
Scientific publications: Time for change

Changes in scientific publishing are "necessary as a matter of urgency" and everyone should have free, open access to UK research findings. So says the UK House of Commons Science & Technology Committee in their report on scientific publishing, published today.

Vitek Tracz, Chairman of the Open Access publisher BioMed Central said: "We welcome this important and forward-looking report which marks the beginning of a new era. Change is essential for science and will benefit society."

Crucially, the report recommends that UK research funding bodies mandate free access to all their research findings. "This will lead to a profound change in the way that scientific literature is published, and validates the author-pays 'Open Access' publishing model which we at BioMed Central pioneered," Tracz remarked.

The Committee urge the UK Government to "act as a proponent for change" and "lead by example".

Some UK funders have already shown great support for the Open Access publishing model. By signing agreements with BioMed Central, JISC and NHS England have made it possible for many UK researchers to publish free of charge in Open Access journals.

The Committee recommends that UK Research Councils follow this lead and make funds available to pay author charges. This would mean that all publicly funded UK researchers would be able to make their research findings Open Access, at no cost to themselves. "This support will help to ensure the success of the author-pays model of publishing," said Tracz.

To improve access to research findings in the short term, the Committee have called for all UK higher education institutions to "establish institutional repositories on which their published output can be stored and from which it can be read, free of charge, online". In addition, they ask Research Councils to "mandate their funded researchers to deposit a copy of all their articles in their institutional repository [] as a condition of
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-207-631-9931
BioMed Central
20-Jul-2004


Page: 1 2

Related biology news :

1. 2nd media alert First Scientific Conference on Childhood Leukaemia
2. First International Scientific Conference on Childhood Leukaemia
3. Dr. Walter Reich, Ph.D., receives prestigious AAAS 2003 Scientific Freedom and Responsibility Award
4. Press briefings at The Gerontological Society of Americas 56th Annual Scientific Meeting
5. Scientific study of twins shows forgiveness has genetic component
6. Scientific equipment including the first European student experiment reaches the ISS
7. Emorys CancerQuest wins top Web award from Scientific American
8. Scientific innovations, social issues and biobusiness at Bio Tech Helsinki 03
9. Scientific balancing act dominates AAAS top ten list of science policy stories for 2002
10. Acorda Therapeutics receives L.W. Freeman Award for Scientific Research
11. Scientific bias helping cause mass extinction

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ACEA Biosciences, ... its Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer ... providing an update on the phase I/II clinical trials for AC0010 in patients with ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only way to ... technology experience. All three tenets were on display at the 2nd Annual DrugDev User ... 40 sponsor, CRO and site organizations to discuss innovation and the future of clinical ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
(Date:11/30/2016)... Nov. 30, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" ... PBT.U), is excited to announce the formation of ... developing preclinical ophthalmology assets through proof of concept. ... created by Portage Pharmaceuticals Limited and being developed ... surface and anterior segment diseases. This agent has ...
Breaking Biology Technology:
Cached News: